CF PharmTech, Inc. (Stock Code: 2652) Adopts Electronic Dissemination of Corporate Communications

Bulletin Express11-26

On 26 November 2025, CF PharmTech, Inc. (長風藥業股份有限公司) announced a switch to electronic dissemination of its corporate communications. According to the updated practices effective from 31 December 2023, future documents such as the directors’ report, annual and interim reports (including relevant summaries), notices of meetings, listing documents, circulars, and proxy forms will be accessed digitally.

The English and Chinese versions of these materials are now available on the company’s website (https://www.cfpharmtech.com) and the HKExnews website (www.hkexnews.hk). Non-registered shareholders holding shares through intermediaries are advised to provide their email addresses to their respective banks, brokers, custodians, or nominees in order to stay informed.

Those who prefer printed copies can complete and return the Reply Form or email CFPharm.ecom@computershare.com.hk, specifying name, address, and the request for physical documents. For more information or inquiries, emailing the same address is recommended. This change aligns with ongoing efforts to adopt a broader paperless listing regime for corporate communications.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1146328846?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-26 18:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146328846","market":"hk","top_or_hot":-1,"title":"CF PharmTech, Inc. (Stock Code: 2652) Adopts Electronic Dissemination of Corporate Communications","media":"Bulletin Express","content":"<p>On 26 November 2025, CF PharmTech, Inc. (長風藥業股份有限公司) announced a switch to electronic dissemination of its corporate communications. According to the updated practices effective from 31 December 2023, future documents such as the directors’ report, annual and interim reports (including relevant summaries), notices of meetings, listing documents, circulars, and proxy forms will be accessed digitally.</p>\n<p>The English and Chinese versions of these materials are now available on the company’s website (https://www.cfpharmtech.com) and the HKExnews website (www.hkexnews.hk). Non-registered shareholders holding shares through intermediaries are advised to provide their email addresses to their respective banks, brokers, custodians, or nominees in order to stay informed.</p>\n<p>Those who prefer printed copies can complete and return the Reply Form or email CFPharm.ecom@computershare.com.hk, specifying name, address, and the request for physical documents. For more information or inquiries, emailing the same address is recommended. This change aligns with ongoing efforts to adopt a broader paperless listing regime for corporate communications.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PharmTech, Inc. (Stock Code: 2652) Adopts Electronic Dissemination of Corporate Communications</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PharmTech, Inc. (Stock Code: 2652) Adopts Electronic Dissemination of Corporate Communications\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-26 18:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 26 November 2025, CF PharmTech, Inc. (長風藥業股份有限公司) announced a switch to electronic dissemination of its corporate communications. According to the updated practices effective from 31 December 2023, future documents such as the directors’ report, annual and interim reports (including relevant summaries), notices of meetings, listing documents, circulars, and proxy forms will be accessed digitally.</p>\n<p>The English and Chinese versions of these materials are now available on the company’s website (https://www.cfpharmtech.com) and the HKExnews website (www.hkexnews.hk). Non-registered shareholders holding shares through intermediaries are advised to provide their email addresses to their respective banks, brokers, custodians, or nominees in order to stay informed.</p>\n<p>Those who prefer printed copies can complete and return the Reply Form or email CFPharm.ecom@computershare.com.hk, specifying name, address, and the request for physical documents. For more information or inquiries, emailing the same address is recommended. This change aligns with ongoing efforts to adopt a broader paperless listing regime for corporate communications.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02652","symbol_name":"长风药业","start_time":0,"source_url":"","article_id":"1146328846","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146328846","pubTimestamp":1764151265,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 26 November 2025, CF PharmTech, Inc. (長風藥業股份有限公司) announced a switch to electronic dissemination of its corporate communications. According to the updated practices effective from 31 December...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02652":"长风药业"},"translate_title":"CF PharmTech，Inc.（股份代号：2652）采用电子方式发布企业通讯","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02652":1},"content_text":"On 26 November 2025, CF PharmTech, Inc. (長風藥業股份有限公司) announced a switch to electronic dissemination of its corporate communications. According to the updated practices effective from 31 December 2023, future documents such as the directors’ report, annual and interim reports (including relevant summaries), notices of meetings, listing documents, circulars, and proxy forms will be accessed digitally.\nThe English and Chinese versions of these materials are now available on the company’s website (https://www.cfpharmtech.com) and the HKExnews website (www.hkexnews.hk). Non-registered shareholders holding shares through intermediaries are advised to provide their email addresses to their respective banks, brokers, custodians, or nominees in order to stay informed.\nThose who prefer printed copies can complete and return the Reply Form or email CFPharm.ecom@computershare.com.hk, specifying name, address, and the request for physical documents. For more information or inquiries, emailing the same address is recommended. This change aligns with ongoing efforts to adopt a broader paperless listing regime for corporate communications.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1146328846","isCrawlerRequest":true}